Evidence map›Paper›PMID 23904599›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers.

Abdessattar Khlaifia, Hanad Farah, Florian Gackiere, Fabien Tell

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Endocannabinoids in Body Weight Control.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  5. Article
  6. Review
  7. Article
  8. Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  9. Article
  10. Control of synaptic function by endocannabinoid-mediated retrograde signaling.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2014
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Abdessattar KhlaifiaAix-Marseille University, National Center of Scientific Research, Research Center in Neurobiology-Neurophysiology of Marseille, Coeducational Research Unit 7286, F-13344 Marseille, France.
Hanad Farah
Florian Gackiere
Fabien Tell
Aix-Marseille Université · FRCentre de Recherche en Neurobiologie - Neurophysiologie de Marseille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Presynaptic long-term depression (LTD) of synapse efficacy generally requires coordinated activity between presynaptic and postsynaptic neurons and a retrograde signal synthesized by the postsynaptic cell in an activity-dependent manner. In this study, we examined LTD in the rat nucleus tractus solitarii (NTS), a brainstem nucleus that relays homeostatic information from the internal body to the brain. We found that coactivation of N-methyl-D-aspartate receptors (NMDARs) and type 1 cannabinoid receptors (CB1Rs) induces LTD at the first central excitatory synapse between visceral fibers and NTS neurons. This LTD is presynaptically expressed. However, neither postsynaptic activation of NMDARs nor postsynaptic calcium influx are required for its induction. Direct activation of NMDARs triggers cannabinoid-dependent LTD. In addition, LTD is unaffected by blocking 2-arachidonyl-glycerol synthesis, but its induction threshold is lowered by preventing fatty acid degradation. Altogether, our data suggest that LTD in NTS neurons may be entirely expressed at the presynaptic level by local anandamide synthesis.

Indexed as

AnimalsAnimals, NewbornArachidonic AcidsCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsElectric StimulationEndocannabinoidsEnzyme InhibitorsExcitatory Amino Acid AgentsExcitatory Postsynaptic PotentialsIn Vitro TechniquesLong-Term Synaptic DepressionMaleMedulla OblongataNeuronsPatch-Clamp TechniquesAM 251anandamideArachidonic AcidsCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsEndocannabinoidsEnzyme InhibitorsExcitatory Amino Acid AgentsPiperidinesPolyunsaturated AlkamidesPyrazolesReceptor, Cannabinoid, CB1Receptors, N-Methyl-D-Aspartate

Identifiers

PMID23904599
PMCPMC6618553
OpenAlexW2029418391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.